NCT00817076View on ClinicalTrials.gov

Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Dermatitis, Atopic
Interventions
DRUG

desloratadine

desloratadine syrup; 5.0 mL once daily for 28 days

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00817076 - Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475) | Biotech Hunter | Biotech Hunter